Table 2.
Clinicopathological parameters of BLCA patients in this research.
| Covariates | Type | Total | Test | Train |
|---|---|---|---|---|
| Age (years) | ≤65 | 159 (40.15%) | 84 (42.86%) | 75 (37.5%) |
| >65 | 237 (59.85%) | 112 (57.14%) | 125 (62.5%) | |
| Gender | FEMALE | 104 (26.26%) | 57 (29.08%) | 47 (23.5%) |
| MALE | 292 (73.74%) | 139 (70.92%) | 153 (76.5%) | |
| Grade | High Grade | 375 (95.42%) | 184 (95.34%) | 191 (95.5%) |
| Low Grade | 18 (4.58%) | 9 (4.66%) | 9 (4.5%) | |
| Stage | Stage I-II | 126 (31.98%) | 69 (35.57%) | 57 (28.5%) |
| Stage III-IV | 268 (68.02%) | 125 (64.43%) | 143 (71.5%) | |
| T-stage | T0-T2 | 117 (32.14%) | 68 (37.57%) | 49 (26.77%) |
| T3-T4 | 247 (67.82%) | 113 (62.43%) | 134 (73.22%) | |
| M-stage | M0 | 189 (94.97%) | 89 (95.7%) | 100 (94.34%) |
| M1 | 10 (5.03%) | 4 (4.3%) | 6 (5.66%) | |
| N-stage | N0-N1 | 273 (76.9%) | 130 (75.14%) | 143 (78.57%) |
| N2-N3 | 82 (23.1%) | 43 (22.86%) | 39 (21.43%) |
BLCA, bladder cancer; T, tumor; N, node; M, metastasis.